• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西欧和东欧睾丸癌死亡率趋势。

Western and eastern European trends in testicular cancer mortality.

作者信息

Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E

出版信息

Lancet. 2001 Jun 9;357(9271):1853-4. doi: 10.1016/s0140-6736(00)04973-4.

DOI:10.1016/s0140-6736(00)04973-4
PMID:11410198
Abstract

Testicular cancer is curable if treated appropriately. We used national mortality data to compare specific death rates from the disorder in western and eastern Europe, the USA, and Japan. Testicular cancer mortality rates have fallen by about 70% in the USA and western Europe since the 1970s. In eastern Europe, however, death rates from testicular cancer have been declining only since the late 1980s, and at a much slower rate than that recorded elsewhere (about 20%). Consequently, many avoidable deaths, mainly in young adults, are still occurring in eastern Europe. Available effective treatment strategies for testicular cancer must be implemented in these countries.

摘要

睾丸癌若得到恰当治疗是可治愈的。我们利用国家死亡率数据比较了西欧、东欧、美国和日本该疾病的特定死亡率。自20世纪70年代以来,美国和西欧的睾丸癌死亡率已下降了约70%。然而,在东欧,睾丸癌死亡率直到20世纪80年代末才开始下降,且下降速度比其他地区慢得多(约20%)。因此,在东欧仍有许多本可避免的死亡发生,主要发生在年轻人中。这些国家必须实施现有的有效的睾丸癌治疗策略。

相似文献

1
Western and eastern European trends in testicular cancer mortality.西欧和东欧睾丸癌死亡率趋势。
Lancet. 2001 Jun 9;357(9271):1853-4. doi: 10.1016/s0140-6736(00)04973-4.
2
[Tumors of the testis: a paradigm of a curable neoplasm?].
Recenti Prog Med. 2002 Jan;93(1):16-8.
3
Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality.22个欧洲国家睾丸癌发病率和死亡率的趋势:发病率持续上升,死亡率持续下降。
Int J Cancer. 2006 Jun 15;118(12):3099-111. doi: 10.1002/ijc.21747.
4
Thirty year trends in testicular cancer mortality in Europe: gaps persist between the East and West.欧洲睾丸癌死亡率的三十年趋势:东西方之间的差距依然存在。
Acta Oncol. 2012 Sep;51(7):956-8. doi: 10.3109/0284186X.2012.681701. Epub 2012 May 1.
5
International variations and trends in testicular cancer incidence and mortality.国际睾丸癌发病率和死亡率的变化和趋势。
Eur Urol. 2014 Jun;65(6):1095-106. doi: 10.1016/j.eururo.2013.11.004. Epub 2013 Nov 14.
6
Improved survival for patients with testicular cancer in Europe since 1978. EUROCARE Working Group.自1978年以来欧洲睾丸癌患者的生存率有所提高。欧洲癌症和肿瘤生存率观察研究(EUROCARE)工作组。
Eur J Cancer. 1998 Dec;34(14 Spec No):2236-40. doi: 10.1016/s0959-8049(98)00313-x.
7
Trends of liver cirrhosis mortality in Europe, 1970-1989: age-period-cohort analysis and changing alcohol consumption.1970 - 1989年欧洲肝硬化死亡率趋势:年龄-时期-队列分析与酒精消费变化
Int J Epidemiol. 1997 Feb;26(1):100-9. doi: 10.1093/ije/26.1.100.
8
Global trends in testicular cancer incidence and mortality.全球睾丸癌发病率和死亡率趋势。
Eur Urol. 2011 Aug;60(2):374-9. doi: 10.1016/j.eururo.2011.05.004. Epub 2011 May 17.
9
Global patterns in testicular cancer incidence and mortality in 2020.2020 年全球睾丸癌发病率和死亡率的模式。
Int J Cancer. 2022 Sep 1;151(5):692-698. doi: 10.1002/ijc.33999. Epub 2022 Mar 26.
10
Mortality from causes amenable and non-amenable to medical care: the experience of eastern Europe.可通过医疗护理解决和无法通过医疗护理解决的病因导致的死亡率:东欧的情况
BMJ. 1991 Oct 12;303(6807):879-83. doi: 10.1136/bmj.303.6807.879.

引用本文的文献

1
Prolonged survival after thoracic metastasectomy in patients with nonseminomatous testicular cancer.非精原细胞瘤性睾丸癌患者的胸部转移瘤切除术后长期生存。
Clinics (Sao Paulo). 2024 Feb 14;79:100338. doi: 10.1016/j.clinsp.2024.100338. eCollection 2024.
2
Low socioeconomic position is a risk factor for delay to treatment and mortality of testicular cancer patients in Hungary, a prospective study.在一项前瞻性研究中,匈牙利的研究表明,社会经济地位较低是睾丸癌患者治疗延误和死亡的风险因素。
BMC Public Health. 2021 Sep 19;21(1):1707. doi: 10.1186/s12889-021-11720-w.
3
Trends in incidence, mortality and survival of testicular cancer patients in Belarus.
白俄罗斯睾丸癌患者的发病率、死亡率及生存率趋势
Cent European J Urol. 2019;72(4):357-368. doi: 10.5173/ceju.2019.0073. Epub 2019 Dec 30.
4
A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania.立陶宛基于人群的睾丸癌患者发病率、死亡率和生存率分析。
Medicina (Kaunas). 2019 Aug 30;55(9):552. doi: 10.3390/medicina55090552.
5
Cancer Control in Central and Eastern Europe.中东欧地区的癌症防控
Oncologist. 2016 Oct;21(10):1161-1162. doi: 10.1634/theoncologist.2016-0230. Epub 2016 Jul 8.
6
Global incidence and outcome of testicular cancer.睾丸癌的全球发病率及预后
Clin Epidemiol. 2013 Oct 17;5:417-27. doi: 10.2147/CLEP.S34430.
7
Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer.风险适应性管理中转移性睾丸生殖细胞癌化疗的现状。
Cancer Sci. 2010 Jan;101(1):22-8. doi: 10.1111/j.1349-7006.2009.01373.x. Epub 2009 Sep 26.
8
Epidemiology and treatment delay in testicular cancer patients: a retrospective study.睾丸癌患者的流行病学与治疗延迟:一项回顾性研究。
Int Urol Nephrol. 2008;40(1):143-8. doi: 10.1007/s11255-007-9245-3. Epub 2007 Jul 18.
9
Supply and regulation of medicines.药品供应与监管
BMJ. 2005 Jul 23;331(7510):171-2. doi: 10.1136/bmj.331.7510.171.
10
Measuring the health of nations: analysis of mortality amenable to health care.衡量各国健康状况:对可通过医疗保健改善的死亡率进行分析。
BMJ. 2003 Nov 15;327(7424):1129. doi: 10.1136/bmj.327.7424.1129.